Interestingly, activation of the MAPK and PI3K survival pathways is observed in uveal melanoma; however, driver mutations in BRAF or NRAS commonly present in cutaneous melanoma are not observed in uveal melanoma.15 This evidence concerns the gene BRAF and uveal melanoma.